Robert Hopfner Net Worth & Insider Trades
Robert Hopfner - Director, Inozyme Pharma, Inc
What is Robert Hopfner's Net Worth?
The current estimated net worth of Inozyme Pharma, Inc's Director, Robert Hopfner, is estimated to be about $136.43M . Robert Hopfner owns about 3,661,518 units of Inozyme Pharma, Inc common stock. In the last 3 years at Inozyme Pharma, Inc, Robert Hopfner has sold an estimated value of $0 worth.
What is Robert Hopfner's Past Insider Trading?
Robert Hopfner's largest purchase order was 1,070,000 units , worth over $3.95M on April 20, 2022. In total, Robert Hopfner has made about 8 transactions over 3 years of their time at Inozyme Pharma, Inc. Robert Hopfner usually trades in June, July and March, with the busiest year in 2023. The most recent transaction was a purchase order of 447,932 units , worth over $2.85M on May 15, 2023.
Robert Hopfner
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Robert Hopfner's' Mailing Address?
- Mailing address is C/o Bay City Capital, Llc 750 Battery Street, Suite 400 San Francisco CA 94111 CA
Inozyme Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Axel Bolte | 2020 | $440,099 | - | $4,584,236 | $290,466 | $40,833 | $5,355,634 |
| Axel Bolte | 2019 | $378,000 | $179,313 | $353,470 | - | $60,000 | $970,783 |
| Henric Bjarke | 2020 | $389,782 | - | $506,970 | $187,095 | - | $1,083,847 |
| Henric Bjarke | 2019 | $350,200 | $99,201 | $141,388 | - | - | $590,789 |
| Pedro Huertas | 2020 | $397,843 | - | $604,993 | $159,137 | - | $1,161,973 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1693011/000119312521132657/d24332ddef14a.htm
What are Inozyme Pharma, Inc's Past Insider Trades?
Inozyme Pharma, Inc's most recent insider trade came on May 15, 2023 by Robert Hopfner who bought 447,932 units worth $2.85M . In the last 3 years, insiders at Inozyme Pharma, Inc have sold an estimated value of $7.88M and bought an estimated value of $96.22M worth of shares. Insider trading is most common in July, with the busiest year in 2020. The most active traders at the company are Axel Bolte, Director, Robert Hopfner, Director, and Henric Bjarke, SVP .
Inozyme Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||